Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
26.89
+1.49 (5.87%)
At close: Dec 5, 2025, 4:00 PM EST
26.88
-0.01 (-0.04%)
After-hours: Dec 5, 2025, 7:59 PM EST
Capricor Therapeutics Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for Capricor Therapeutics stock ranges from a low of $13 to a high of $60. The average analyst price target of $32.14 forecasts a 19.52% increase in the stock price over the next year.
Price Target: $32.14 (+19.52%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Capricor Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 4 | 5 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $25 → $50 | Strong Buy | Maintains | $25 → $50 | +85.94% | Dec 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $24 → $60 | Strong Buy | Maintains | $24 → $60 | +123.13% | Dec 3, 2025 |
| Roth Capital | Roth Capital | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | -51.65% | Nov 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | -10.75% | Sep 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | -10.75% | Sep 11, 2025 |
Financial Forecast
Revenue This Year
1.36M
from 22.27M
Decreased by -93.89%
Revenue Next Year
106.57M
from 1.36M
Increased by 7,736.03%
EPS This Year
-2.21
from -1.15
EPS Next Year
-1.86
from -2.21
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 6.3M | 314.5M | ||||
| Avg | 1.4M | 106.6M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -71.7% | 23,023.5% | ||||
| Avg | -93.9% | 7,736.0% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.13 | -0.84 | ||||
| Avg | -2.21 | -1.86 | ||||
| Low | -2.19 | -2.52 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.